IQVIA's Dr. Cynthia Verst Testifies Before Congressional Subcommittee on More Efficient Path to Early Clinical Development in the United States

Go back to IQVIA's Dr. Cynthia Verst Testifies Before Congressional Subcommittee on More Efficient Path to Early Clinical Development in the United States
(NYSE: IQV) Delayed: 207.32 +8.80 (4.43%)
Previous Close $198.52    52 Week High
Open $216.66    52 Week Low
Day High $217.05    P/E N/A 
Day Low $204.15    EPS
Volume 1,351,962